Page last updated: 2024-08-17

adenosine diphosphate and orbofiban

adenosine diphosphate has been researched along with orbofiban in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asai, F; Naganuma, H; Ogawa, T; Sugidachi, A	1
Feuerstein, GZ; Friedman, SM; Gibbs, SK; Racanelli, AL; Seiffert, DA; Zondlo, SC	1

Other Studies

2 other study(ies) available for adenosine diphosphate and orbofiban

Article	Year
Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs. Thrombosis research, 2000, Mar-01, Volume: 97, Issue:5 Topics: Adenosine Diphosphate; Administration, Oral; Alanine; Animals; Arteriovenous Shunt, Surgical; Aspirin; beta-Alanine; Bleeding Time; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Guinea Pigs; Hemostasis; Hypercholesterolemia; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Urea	2000
Differential effect of the GPIIb/IIIa antagonist orbofiban on human platelet aggregate formation in vitro. Thrombosis research, 2003, May-01, Volume: 110, Issue:2-3 Topics: Adenosine Diphosphate; Alanine; Blood Platelets; Humans; In Vitro Techniques; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Time Factors	2003

Article

Year

Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs.

Thrombosis research, 2000, Mar-01, Volume: 97, Issue:5

Topics: Adenosine Diphosphate; Administration, Oral; Alanine; Animals; Arteriovenous Shunt, Surgical; Aspirin; beta-Alanine; Bleeding Time; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Guinea Pigs; Hemostasis; Hypercholesterolemia; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Urea

2000

Differential effect of the GPIIb/IIIa antagonist orbofiban on human platelet aggregate formation in vitro.

Thrombosis research, 2003, May-01, Volume: 110, Issue:2-3

Topics: Adenosine Diphosphate; Alanine; Blood Platelets; Humans; In Vitro Techniques; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Time Factors

2003